Robotic-Assisted Eye Surgery Market Report 2025

The robotic-assisted eye surgery market size has grown rapidly in recent years. It will grow from $1.22 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth observed during the historic period can be attributed to the rising demand for precision in ophthalmic procedures, the increasing prevalence of age-related eye diseases, greater awareness of the role of robotics in surgery, the expansion of private ophthalmic clinics, and higher healthcare spending in developed economies.

The robotic-assisted eye surgery market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The projected growth in the forecast period can be linked to the rising incidence of diabetic and hypertensive eye disorders, the growing preference for outpatient robotic surgeries, wider availability of robotic systems in emerging markets, the expansion of ophthalmology centers in rural areas, and increasing investments in robotic surgery training programs. Key trends expected during this period include advancements in microsurgical robotics, the development of AI-driven surgical assistance tools, greater investment in research and development for precision ophthalmology, the introduction of compact and mobile robotic platforms, and the emergence of autonomous and remote-controlled eye surgery systems.

The growing prevalence of eye disorders is expected to drive the expansion of the robotic-assisted eye surgery market in the coming years. Eye disorders are medical conditions that impact the structure or function of the eye, potentially resulting in vision impairment or blindness. The rise in such conditions is largely attributed to increasing screen time, which causes digital eye strain, dry eyes, and blurred vision due to prolonged exposure without sufficient breaks. Robotic-assisted eye surgery addresses these disorders by enhancing surgical precision, minimizing human error, and enabling minimally invasive procedures, which improve patient outcomes and shorten recovery times. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US government agency, reported that 20.5 million people aged 40 and older in the United States representing 17.2% of that age group were expected to have cataracts in at least one eye in 2024. This figure is projected to exceed 30 million by 2028. As a result, the growing prevalence of eye disorders is fueling the demand for robotic-assisted eye surgery.

Companies in the robotic-assisted eye surgery market are increasingly focused on developing advanced technologies, such as robotic-assisted phacoemulsification platforms, to improve surgical precision, lower complication risks, and enhance patient outcomes. A robotic-assisted phacoemulsification platform is a system that uses robotic technology to assist surgeons in performing cataract removal procedures with greater accuracy. For instance, in May 2024, ForSight Robotics, an Israel-based developer of robotic surgery platforms, introduced the ORYOM surgical robotics platform capable of conducting a complete, remote robotic cataract procedure. The platform features a miniature robotic hand with 14 degrees of freedom and hybrid kinematics, offering superior maneuverability inside the eye. It integrates artificial intelligence, advanced imaging, and compact mechanical components to ensure consistent and precise surgical performance. Additionally, stereoscopic imaging enhances depth perception and provides real-time feedback, while machine learning enables the platform to adapt and improve with each procedure.

In March 2025, Alcon Inc., a Switzerland-based eye care company, acquired LENSAR Inc. for $430 million. This acquisition enables Alcon to leverage LENSAR’s advanced laser technology and surgical planning software to deliver more accurate, efficient, and integrated solutions in robotic-assisted cataract surgery. LENSAR Inc. is a US-based provider specializing in robotic-assisted eye surgery.

Major players in the robotic-assisted eye surgery market are Johnson & Johnson, Medtronic Plc, Stryker Corp., ZEISS Group, Alcon Inc., Intuitive Surgical Operations Inc., Bausch + Lomb Corp., Leica Microsystems, Lumenis Ltd., Lumibird Medical, Topcon Healthcare, IRIDEX Corp., ForSight Robotics Ltd., Aaren Scientific Inc., Hansen Medical, Prasad Netralaya, Haag-Streit Group, Nidek Co. Ltd., Ophthorobotics AG, and Preceyes BV.

North America was the largest region in the robotic-assisted eye surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in robotic-assisted eye surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the robotic-assisted eye surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Robotic-assisted eye surgery refers to procedures in which robotic systems or tools are used to support ophthalmic surgeons in carrying out highly precise and minimally invasive eye operations. These technologies improve the surgeon’s abilities by offering enhanced precision, stability, and control, which are especially critical for delicate and complex interventions involving the retina, cornea, or other ocular structures.

The primary categories of robotic-assisted eye surgery include robotic systems, instruments and accessories, as well as software and services. Robotic systems are integrated setups combining mechanical parts, sensors, control mechanisms, and software, designed to perform tasks either automatically or semi-automatically with high precision, consistency, and minimal human input. The surgeries involved include cataract surgery, retinal surgery, corneal surgery, glaucoma surgery, refractive surgery, and others, utilizing technologies such as haptic feedback systems, image-guided platforms, AI-powered robotic systems, and more. These procedures are applied in anterior segment surgeries, posterior segment surgeries, corneal surgeries, and other applications, serving a range of end users including hospitals, ambulatory surgical centers (ASCs), specialized ophthalmic clinics, and academic or research institutions.

The robotic-assisted eye surgery market research report is one of a series of new reports that provides robotic-assisted eye surgery market statistics, including robotic-assisted eye surgery industry global market size, regional shares, competitors with a robotic-assisted eye surgery market share, robotic-assisted eye surgery market segments, market trends and opportunities, and any further data you may need to thrive in the robotic-assisted eye surgery industry. This robotic-assisted eye surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The robotic-assisted eye surgery market consists of revenues earned by entities by providing services such as training and support services, tele-surgical support services, data management, maintenance, upgrade services, and remote surgery assistance. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic-assisted eye surgery market also includes sales of wearable visualization devices, robotic-compatible surgical microscopes, microsurgical instruments, and navigation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.